EMBL-EBI | Chemical Biology Resources | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:750075 - briakinumab
| ChEBI ID | CHEBI:750075 |
| ChEBI Name | briakinumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Biological Role: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. |
| Applications: | antipsoriatic A drug used to treat psoriasis. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| briakinumab (CHEBI:750075) has role antipsoriatic (CHEBI:50748) |
| briakinumab (CHEBI:750075) has role immunosuppressive agent (CHEBI:35705) |
| briakinumab (CHEBI:750075) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| A-796874.0 | ChEMBL |
| ABT-874 | ChEMBL |
| Briakinumab | ChEMBL |
| BSF 415977 | ChEMBL |
| BSF-415977 | ChEMBL |
| J-695 | ChEMBL |
| Brand Name | Source |
|---|---|
| Ozespa | ChEMBL |